Form 8-K - Current report:
SEC Accession No. 0001558370-24-013344
Filing Date
2024-10-16
Accepted
2024-10-16 16:25:24
Documents
13
Period of Report
2024-10-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K capr-20241016x8k.htm   iXBRL 8-K 46104
  Complete submission text file 0001558370-24-013344.txt   165649

Data Files

Seq Description Document Type Size
2 EX-101.SCH capr-20241016.xsd EX-101.SCH 3258
3 EX-101.LAB capr-20241016_lab.xml EX-101.LAB 15269
4 EX-101.PRE capr-20241016_pre.xml EX-101.PRE 9657
15 EXTRACTED XBRL INSTANCE DOCUMENT capr-20241016x8k_htm.xml XML 4728
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34058 | Film No.: 241374928
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)